HEADER HYDROLASE/HYDROLASE INHIBITOR 06-JUN-01 1JBU TITLE COAGULATION FACTOR VII ZYMOGEN (EGF2/PROTEASE) IN COMPLEX WITH TITLE 2 INHIBITORY EXOSITE PEPTIDE A-183 COMPND MOL_ID: 1; COMPND 2 MOLECULE: COAGULATION FACTOR VII; COMPND 3 CHAIN: H; COMPND 4 FRAGMENT: HEAVY CHAIN; COMPND 5 SYNONYM: SERUM PROTHROMBIN CONVERSION ACCELERATOR; COMPND 6 EC: 3.4.21.21; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: COAGULATION FACTOR VII; COMPND 10 CHAIN: L; COMPND 11 FRAGMENT: LIGHT CHAIN; COMPND 12 SYNONYM: SERUM PROTHROMBIN CONVERSION ACCELERATOR; COMPND 13 EC: 3.4.21.21; COMPND 14 ENGINEERED: YES; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: PEPTIDE EXOSITE INHIBITOR A-183; COMPND 17 CHAIN: X; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HIGH-FIVE; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PACGP67; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 16 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: HIGH-FIVE; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PACGP67; SOURCE 21 MOL_ID: 3; SOURCE 22 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 23 ORGANISM_TAXID: 562; SOURCE 24 GENE: SYNTHETIC CONSTRUCT; SOURCE 25 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 26 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 27 EXPRESSION_SYSTEM_STRAIN: 27C7; SOURCE 28 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 29 EXPRESSION_SYSTEM_PLASMID: PA-100-Z KEYWDS SHIFTED REGISTRATION, BETA-STRANDS, HYDROLASE-HYDROLASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.EIGENBROT,D.KIRCHHOFER,M.S.DENNIS,L.SANTELL,R.A.LAZARUS,J.STAMOS, AUTHOR 2 M.H.ULTSCH REVDAT 7 16-AUG-23 1JBU 1 REMARK REVDAT 6 31-JAN-18 1JBU 1 JRNL REVDAT 5 24-JAN-18 1JBU 1 JRNL REMARK REVDAT 4 13-JUL-11 1JBU 1 VERSN REVDAT 3 24-FEB-09 1JBU 1 VERSN REVDAT 2 01-APR-03 1JBU 1 JRNL REVDAT 1 11-JUL-01 1JBU 0 JRNL AUTH C.EIGENBROT,D.KIRCHHOFER,M.S.DENNIS,L.SANTELL,R.A.LAZARUS, JRNL AUTH 2 J.STAMOS,M.H.ULTSCH JRNL TITL THE FACTOR VII ZYMOGEN STRUCTURE REVEALS REREGISTRATION OF JRNL TITL 2 BETA STRANDS DURING ACTIVATION. JRNL REF STRUCTURE V. 9 627 2001 JRNL REFN ISSN 0969-2126 JRNL PMID 11470437 JRNL DOI 10.1016/S0969-2126(01)00624-4 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.ROBERGE,L.SANTELL,M.S.DENNIS,C.EIGENBROT,M.A.DWYER, REMARK 1 AUTH 2 R.A.LAZARUS REMARK 1 TITL A NOVEL EXOSITE ON COAGULATION FACTOR VIIA AND ITS MOLECULAR REMARK 1 TITL 2 INTERACTIONS WITH A NEW CLASS OF PEPTIDE INHIBITORS REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 1 REFERENCE 2 REMARK 1 AUTH D.W.BANNER,A.D'ARCY,C.CHENE,F.K.WINKLER,A.GUHA, REMARK 1 AUTH 2 W.H.KONIGSBERG,Y.NEMERSON,D.KIRCHHOFER REMARK 1 TITL THE CRYSTAL STRUCTURE OF THE COMPLEX OF BLOOD COAGULATION REMARK 1 TITL 2 FACTOR VIIA WITH SOLUBLE TISSUE FACTOR REMARK 1 REF NATURE V. 380 41 1996 REMARK 1 REFN ISSN 0028-0836 REMARK 1 DOI 10.1038/380041A0 REMARK 1 REFERENCE 3 REMARK 1 AUTH E.ZHANG,R.ST.CHARLES,A.TULINSKY REMARK 1 TITL STRUCTURE OF EXTRACELLULAR TISSUE FACTOR COMPLEXED WITH REMARK 1 TITL 2 FACTOR VIIA INHIBITED WITH A BPTI MUTANT REMARK 1 REF J.MOL.BIOL. V. 285 2089 1999 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1006/JMBI.1998.2452 REMARK 1 REFERENCE 4 REMARK 1 AUTH G.KEMBALL-COOK,D.J.JOHNSON,E.G.TUDDENHAM,K.HARLOS REMARK 1 TITL CRYSTAL STRUCTURE OF ACTIVE SITE-INHIBITED HUMAN COAGULATION REMARK 1 TITL 2 FACTOR VIIA (DES-GLA) REMARK 1 REF J.STRUCT.BIOL. V. 127 213 1999 REMARK 1 REFN ISSN 1047-8477 REMARK 1 DOI 10.1006/JSBI.1999.4158 REMARK 1 REFERENCE 5 REMARK 1 AUTH A.C.PIKE,A.M.BRZOZOWSKI,S.M.ROBERTS,O.H.OLSEN,E.PERSSON REMARK 1 TITL STRUCTURE OF HUMAN FACTOR VIIA AND ITS IMPLICATIONS FOR THE REMARK 1 TITL 2 TRIGGERING OF BLOOD COAGULATION REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 96 8925 1999 REMARK 1 REFN ISSN 0027-8424 REMARK 1 DOI 10.1073/PNAS.96.16.8925 REMARK 1 REFERENCE 6 REMARK 1 AUTH M.S.DENNIS,C.EIGENBROT,N.J.SKELTON,M.H.ULTSCH,L.SANTELL, REMARK 1 AUTH 2 M.A.DWYER,M.P.O'CONNELL,R.A.LAZARUS REMARK 1 TITL PEPTIDE EXOSITE INHIBITORS OF FACTOR VIIA AS ANTICOAGULANTS REMARK 1 REF NATURE V. 404 465 2000 REMARK 1 REFN ISSN 0028-0836 REMARK 1 DOI 10.1038/35006574 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 98.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.200 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 100000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.1000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 33404 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.100 REMARK 3 FREE R VALUE TEST SET COUNT : 698 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.07 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3230 REMARK 3 BIN R VALUE (WORKING SET) : 0.3130 REMARK 3 BIN FREE R VALUE : 0.3400 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 1.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 59 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.044 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2415 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 14 REMARK 3 SOLVENT ATOMS : 198 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 33.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.01000 REMARK 3 B22 (A**2) : 0.50000 REMARK 3 B33 (A**2) : -0.25000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM SIGMAA (A) : 0.21 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.26 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.100 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.970 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 4.470 ; 4.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 4.070 ; 4.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 5.900 ; 6.000 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : MSI_XPLOR_PARHCSDX REMARK 3 PARAMETER FILE 2 : PARAM.SO4 REMARK 3 PARAMETER FILE 3 : PARWAT.PRO REMARK 3 PARAMETER FILE 4 : PARAM.BDN REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : MSI_XPLOR_TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : TOP.SO4 REMARK 3 TOPOLOGY FILE 3 : TOPWAT.PRO REMARK 3 TOPOLOGY FILE 4 : TOP.BDN REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1JBU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-JUN-01. REMARK 100 THE DEPOSITION ID IS D_1000013599. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-DEC-99 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.05 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : ADSC (QUANTUM) REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33624 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 35.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 4.044 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.77 REMARK 200 R MERGE FOR SHELL (I) : 0.42200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1DAN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HEPES, AMMONIUM SULFATE, GLYCEROL, PEG REMARK 280 400, BENZAMIDINE, CALCIUM CHLORIDE, PH 7.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.72000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.42000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.25500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 42.42000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.72000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.25500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3930 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14640 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, L, X REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3430 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15140 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 -33.72000 REMARK 350 BIOMT2 1 0.000000 -1.000000 0.000000 42.25500 REMARK 350 BIOMT3 1 0.000000 0.000000 -1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, X REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE H 16 REMARK 465 VAL H 17 REMARK 465 GLY H 18 REMARK 465 GLY H 19 REMARK 465 LEU H 73 REMARK 465 SER H 74 REMARK 465 GLU H 75 REMARK 465 GLY H 143 REMARK 465 GLN H 144 REMARK 465 LEU H 145 REMARK 465 LEU H 146 REMARK 465 ASP H 147 REMARK 465 ARG H 148 REMARK 465 GLY H 149 REMARK 465 ALA H 150 REMARK 465 ARG L 144 REMARK 465 ASN L 145 REMARK 465 ALA L 146 REMARK 465 SER L 147 REMARK 465 LYS L 148 REMARK 465 PRO L 149 REMARK 465 GLN L 150 REMARK 465 GLY L 151 REMARK 465 ARG L 152 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 ASP H 72 REMARK 475 HIS H 76 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS H 24 CE NZ REMARK 480 ASP H 77 CG OD1 OD2 REMARK 480 VAL H 170E CG1 CG2 REMARK 480 SER H 188A OG REMARK 480 LYS H 188 CG CD CE NZ REMARK 480 ASP H 189 CG OD1 OD2 REMARK 480 SER H 190 OG REMARK 480 GLU L 116 OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU H 68 CA - CB - CG ANGL. DEV. = 14.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS H 24 19.76 59.63 REMARK 500 ASN H 63 -177.70 -172.79 REMARK 500 ASP H 77 -30.06 71.48 REMARK 500 SER H 190 -1.47 -165.89 REMARK 500 LYS H 192 -72.31 -55.68 REMARK 500 ALA H 221A 167.36 71.64 REMARK 500 GLN L 100 -95.12 -118.35 REMARK 500 THR L 108 -179.08 -64.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 THE AUTHORS ARE UNCERTAIN OF THE TRUE IDENTITY OF THE REMARK 600 HET GROUP BEN, AND USED BENZAMIDINE AS A CONVENIENCE. REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 SO4 H 308 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 H 308 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BEN H 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN X OF PEPTIDE EXOSITE REMARK 800 INHIBITOR A-183 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1DAN RELATED DB: PDB REMARK 900 TISSUE FACTOR/FACTOR VIIA COMPLEX REMARK 900 RELATED ID: 1FAK RELATED DB: PDB REMARK 900 TISSUE FACTOR/FACTOR VIIA/BPTI COMPLEX REMARK 900 RELATED ID: 1QFK RELATED DB: PDB REMARK 900 FACTOR VIIA DES-GLA REMARK 900 RELATED ID: 1CVW RELATED DB: PDB REMARK 900 FACTOR VIIA DES-GLA REMARK 900 RELATED ID: 1DVA RELATED DB: PDB REMARK 900 FACTOR VIIA(DES-GLA)/PEPTIDE E-76 COMPLEX DBREF 1JBU H 16 257 UNP P08709 FA7_HUMAN 213 466 DBREF 1JBU L 90 152 UNP P08709 FA7_HUMAN 150 212 DBREF 1JBU X 1 15 PDB 1JBU 1JBU 1 15 SEQRES 1 H 254 ILE VAL GLY GLY LYS VAL CYS PRO LYS GLY GLU CYS PRO SEQRES 2 H 254 TRP GLN VAL LEU LEU LEU VAL ASN GLY ALA GLN LEU CYS SEQRES 3 H 254 GLY GLY THR LEU ILE ASN THR ILE TRP VAL VAL SER ALA SEQRES 4 H 254 ALA HIS CYS PHE ASP LYS ILE LYS ASN TRP ARG ASN LEU SEQRES 5 H 254 ILE ALA VAL LEU GLY GLU HIS ASP LEU SER GLU HIS ASP SEQRES 6 H 254 GLY ASP GLU GLN SER ARG ARG VAL ALA GLN VAL ILE ILE SEQRES 7 H 254 PRO SER THR TYR VAL PRO GLY THR THR ASN HIS ASP ILE SEQRES 8 H 254 ALA LEU LEU ARG LEU HIS GLN PRO VAL VAL LEU THR ASP SEQRES 9 H 254 HIS VAL VAL PRO LEU CYS LEU PRO GLU ARG THR PHE SER SEQRES 10 H 254 GLU ARG THR LEU ALA PHE VAL ARG PHE SER LEU VAL SER SEQRES 11 H 254 GLY TRP GLY GLN LEU LEU ASP ARG GLY ALA THR ALA LEU SEQRES 12 H 254 GLU LEU MET VAL LEU ASN VAL PRO ARG LEU MET THR GLN SEQRES 13 H 254 ASP CYS LEU GLN GLN SER ARG LYS VAL GLY ASP SER PRO SEQRES 14 H 254 ASN ILE THR GLU TYR MET PHE CYS ALA GLY TYR SER ASP SEQRES 15 H 254 GLY SER LYS ASP SER CYS LYS GLY ASP SER GLY GLY PRO SEQRES 16 H 254 HIS ALA THR HIS TYR ARG GLY THR TRP TYR LEU THR GLY SEQRES 17 H 254 ILE VAL SER TRP GLY GLN GLY CYS ALA THR VAL GLY HIS SEQRES 18 H 254 PHE GLY VAL TYR THR ARG VAL SER GLN TYR ILE GLU TRP SEQRES 19 H 254 LEU GLN LYS LEU MET ARG SER GLU PRO ARG PRO GLY VAL SEQRES 20 H 254 LEU LEU ARG ALA PRO PHE PRO SEQRES 1 L 63 ILE CYS VAL ASN GLU ASN GLY GLY CYS GLU GLN TYR CYS SEQRES 2 L 63 SER ASP HIS THR GLY THR LYS ARG SER CYS ARG CYS HIS SEQRES 3 L 63 GLU GLY TYR SER LEU LEU ALA ASP GLY VAL SER CYS THR SEQRES 4 L 63 PRO THR VAL GLU TYR PRO CYS GLY LYS ILE PRO ILE LEU SEQRES 5 L 63 GLU LYS ARG ASN ALA SER LYS PRO GLN GLY ARG SEQRES 1 X 15 GLU GLU TRP GLU VAL LEU CYS TRP THR TRP GLU THR CYS SEQRES 2 X 15 GLU ARG HET SO4 H 308 5 HET BEN H 300 9 HETNAM SO4 SULFATE ION HETNAM BEN BENZAMIDINE FORMUL 4 SO4 O4 S 2- FORMUL 5 BEN C7 H8 N2 FORMUL 6 HOH *198(H2 O) HELIX 1 1 CYS H 22 GLU H 26 5 5 HELIX 2 2 ALA H 55 ASP H 60 5 6 HELIX 3 3 GLU H 125 THR H 129C 1 8 HELIX 4 4 LEU H 129D VAL H 129G 5 4 HELIX 5 5 PRO H 161 LEU H 163 5 3 HELIX 6 6 MET H 164 LEU H 169 1 6 HELIX 7 7 GLN H 170 ARG H 170C 5 4 HELIX 8 8 ASN H 175 TYR H 179 1 5 HELIX 9 9 SER H 190 SER H 195 1 6 HELIX 10 10 TYR H 234 SER H 244 1 11 HELIX 11 11 ASN L 93 CYS L 98 5 6 HELIX 12 12 ILE L 138 LYS L 143 1 6 SHEET 1 A 8 GLU X 4 CYS X 7 0 SHEET 2 A 8 LEU H 251 ALA H 254 -1 O LEU H 251 N LEU X 6 SHEET 3 A 8 GLU H 80 PRO H 91 1 O VAL H 88 N LEU H 252 SHEET 4 A 8 ILE H 65 GLY H 69 -1 N ALA H 66 O ARG H 83 SHEET 5 A 8 GLN H 30 VAL H 35 -1 O LEU H 32 N VAL H 67 SHEET 6 A 8 ALA H 39 LEU H 46 -1 N ALA H 39 O VAL H 35 SHEET 7 A 8 TRP H 51 SER H 54 -1 N VAL H 53 O THR H 45 SHEET 8 A 8 ALA H 104 LEU H 108 -1 O ALA H 104 N SER H 54 SHEET 1 B 6 LEU H 153 LEU H 158 0 SHEET 2 B 6 PHE H 135 GLY H 140 -1 O SER H 136 N VAL H 157 SHEET 3 B 6 PRO H 198 TYR H 203 -1 O PRO H 198 N SER H 139 SHEET 4 B 6 THR H 206 TRP H 215 -1 O THR H 206 N TYR H 203 SHEET 5 B 6 HIS H 224 ARG H 230 -1 N VAL H 227 O TRP H 215 SHEET 6 B 6 MET H 180 SER H 185 -1 O PHE H 181 N TYR H 228 SHEET 1 C 2 TYR L 101 SER L 103 0 SHEET 2 C 2 SER L 111 ARG L 113 -1 O SER L 111 N SER L 103 SHEET 1 D 2 TYR L 118 LEU L 120 0 SHEET 2 D 2 CYS L 127 PRO L 129 -1 N THR L 128 O SER L 119 SSBOND 1 CYS H 22 CYS H 27 1555 1555 2.04 SSBOND 2 CYS H 42 CYS H 58 1555 1555 2.03 SSBOND 3 CYS H 122 CYS L 135 1555 1555 2.03 SSBOND 4 CYS H 168 CYS H 182 1555 1555 2.04 SSBOND 5 CYS H 191 CYS H 220 1555 1555 2.03 SSBOND 6 CYS L 91 CYS L 102 1555 1555 2.03 SSBOND 7 CYS L 98 CYS L 112 1555 1555 2.03 SSBOND 8 CYS L 114 CYS L 127 1555 1555 2.04 SSBOND 9 CYS X 7 CYS X 13 1555 1555 2.04 CISPEP 1 PHE H 256 PRO H 257 0 0.07 SITE 1 AC1 2 ARG H 84 ALA L 122 SITE 1 AC2 3 VAL H 35 ASN H 37 LYS H 60C SITE 1 AC3 44 PHE H 59 ASP H 60 LYS H 60A ILE H 60B SITE 2 AC3 44 TRP H 61 LEU H 64 VAL H 85 ILE H 89 SITE 3 AC3 44 ILE H 90 ARG H 134 LEU H 158 ASN H 159 SITE 4 AC3 44 TYR H 184 GLY H 184A SER H 185 ASP H 186 SITE 5 AC3 44 GLY H 187 PHE H 225 LYS H 240 LEU H 241 SITE 6 AC3 44 SER H 244 ARG H 247 GLY H 249 VAL H 250 SITE 7 AC3 44 LEU H 251 LEU H 252 ARG H 253 PRO H 255 SITE 8 AC3 44 HOH H 445 HOH H 520 HOH H 526 HOH X 404 SITE 9 AC3 44 HOH X 429 HOH X 439 HOH X 458 HOH X 464 SITE 10 AC3 44 HOH X 465 HOH X 470 HOH X 471 HOH X 492 SITE 11 AC3 44 HOH X 511 HOH X 515 HOH X 578 HOH X 596 CRYST1 67.440 84.510 84.840 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014828 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011833 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011787 0.00000